It is to be noted that Xu et al. (2021) recently found evidence of RIPK1 activation in human COVID-19 lung pathological samples, cultured human lung organoids and ACE2 transgenic mice infected by SARS-CoV-2 and as one of the drivers of inflammatory cytokine storm [31]. The gene discussed is ACE2; the disease is COVID-19.